Role of combination bortezomib and pegylated liposomal doxorubicin in the management of relapsed and/or refractory multiple myeloma

Jatin J Shah, Robert Z Orlowski, Sheeba K Thomas

Therapeutics and Clinical Risk Management 2009, 5:151-159

Published Date: 22 January 2009